Vigisom Melatonin 2mg Prolonged-Release 30 Tablets
For the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over
Pregnancy: Moderate Risk/avoid
Breast-feeding: Potential Toxicity/avoid
Adverse effects: abdominal pain, dyspepsia, dry mouth, mouth ulceration, nausea, weight gain, hypertension, chest pain, malaise, dizziness, restlessness, nervousness, irritability, anxiety, headache, abnormal dreams , proteinuria, glycosuria, pruritus, rash, dry skin; rarely thirst, flatulence, halitosis, salivation, vomiting, gastritis, hypertriglyceridaemia, angina, palpitation, syncope, hot flushes, aggression, impaired memory, restless legs syndrome, paraesthesia, mood changes, priapism, increased libido, prostatitis, polyuria, haematuria, leucopenia, thrombocytopenia, electrolyte disturbances, muscle spasm, arthritis, lacrimation, visual disturbances, nail disorder; also reported galactorrhoea, mouth and tongue oedema
Dosing regimen: Oral, modified release for adult over 55 years: 2 mg once daily 1–2 hours before bedtime for up to 13 weeks.
Patient advice
- This medicine may make you sleepy. If this happens, do not drive or use tools or machines. Do not drink alcohol.
- Take with or just after food, or a meal.
- Immediate release: Take dose immediately before bed.
- Modified release: Take dose 1–2 hours before bed. Swallow this medicine whole, do not crush or chew. However, if you are unable to swallow tablets, or an immediate release effect is desired, the modified release tablet can be crushed and mixed with cold food or drink. Crushing makes this an immediate release preparation and therefore should be taken immediately before bed—discuss with your doctor or pharmacist first.
